A Study On Financial Fraud And Governance Of Pharmaceutical Companies From The Perspective Of Risk Factors

The pharmaceutical industry is related to the national health care and the people’s livelihood.At present,the aging trend in our country appears year by year.The medical resources demand is continuously rising,and its economic value is considerable.At the same time of the rapid development of the pharmaceutical industry,financial fraud of listed companies in the pharmaceutical industry emerge in endlessly,the traced reason is that the cost of financial fraud is too low,the relevant regulatory mechanism is not perfect.The financial fraud of many companies in the pharmaceutical industry not only seriously affects the interests of consumers and related investors,but also affects the economic market order of the pharmaceutical industry.Therefore,it is important to put forward feasible management measures as soon as possible to prevent financial fraud fundamentally.Its case analysis has the characteristics of the enterprise,but also reflects the commonness of the industry,and has research value.This paper will be carried out from six parts.First,according to the background research,we know that the importance of the pharmaceutical industry in our economy has increased,and the financial fraud cases of the pharmaceutical industry have increased in recent years.This paper believes that the study of financial fraud cases of listed companies in the pharmaceutical industry has practical significance.Second,by looking for information and reading literature,this paper chooses risk factor theory and financial fraud theory as the theoretical basis of this paper,and through the financial fraud case analysis of listed companies in the pharmaceutical industry,combined with statistical method,icon method and other statistical analysis methods to summarize the characteristics of the pharmaceutical industry,financial fraud characteristics.Have an overall understanding of financial fraud of listed companies in the pharmaceutical industry.Third,on the basis of the summary of the current situation of financial fraud in the pharmaceutical industry,combined with the analysis of T company case,T company case analysis,from the industry common transition to individual characteristics,comparative analysis of T company financial data,combined with internal governance mechanism,internal control effectiveness and other factors of comprehensive analysis,analysis of T company used financial fraud means,On this basis,the consequences are analyzed.The fourth choice is fraud risk factor theory as the theoretical basis to analyze the reasons and motivations of T company’s financial fraud.Fifth,based on the above analysis,this paper is divided into five levels of practical and feasible management measures.Finally,we deeply explore the enlightenment brought by T company’s financial fraud,and put forward a set of sound and valuable system for the governance of financial fraud.Based on the in-depth analysis of financial fraud means analysis,consequence analysis,motivation analysis and other contents of this case,the conclusion is summarized as follows: T company’s financial fraud is avoidable and preventable,and the management measures proposed according to the risk factor theory are more comprehensive and more practical value;The individual case and the industry case are common,so the governance measures proposed based on the individual case can also be applied to the industry.